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Exposure to multiple chemical combina-
tions occurs throughout our lives from air,
water, soil, food, and household products.
Environmental contamination by multiple
chemicals, including endocrine disruptors
(EDs), over the last 50 years has been sug-
gested as a cause of human health disorders
(Andersson et al. 2001; Colborn et al.
1996; Perera et al. 2002; Safe 2000; Sharpe
and Skakkebaek 1993; Toppari et al. 1996).
EDs are chemicals that disturb the function
of natural hormones in humans and wildlife
(Andersson et al. 2001; Colborn et al.
1996; Safe 2000). In animal experiments,
potential EDs have adverse effects on the
development and/or function of the repro-
ductive and nervous systems, particularly
when exposure occurs during fetal or
neonatal periods (Colborn et al. 1996;
Newbold 2001; Newbold et al. 1984;
Williams et al. 2001). Similarly, human
fetuses and infants are significantly more
sensitive to a variety of environmental toxi-
cants than adults (Charnley and Putzrath
2001; Needam and Sexton 2000; Perera
et al. 2002). Several investigators have
shown that fetuses and young children are
especially vulnerable to the toxic effects of
environmental tobacco smoke, pesticides,
polychlorinated biphenyls (PCBs), and
metals (Calabrese 1986; Jacobson and
Jacobson 1996; Moore and Persaud 1998;
Needleman 1979; Perera 1996; Whyatt and
Perera 1995; WHO 1986).
The current risk assessment strategy,
established in 1983 by the U.S. National
Research Council (NRC), is based on the
risk of exposure to only single chemicals
and focuses on the adverse health effects on
adults not children or fetuses (NRC 1983).
It does not even suppose the risk of com-
plex mixtures of chemicals to human
fetuses. Several investigations have shown
that combined effects of multiple chemicals
enhance the proliferation of human breast
cancer cells (Payne et al. 2001) and induce
congenital anomalies in rats (Gray et al.
2001; Price et al. 2000). Our recent studies
in Japan using human umbilical cords have
shown that human fetuses are exposed to
multiple chemicals (Mori 2001; Mori et al.
2001; Todaka and Mori 2002). There is
genuine concern that these multiple chemi-
cal exposures in humans may cause delayed
long-term adverse health effects. Therefore,
in addition to the current risk assessment, a
new method of health risk assessment of
fetal exposure to multiple chemicals must
be developed.
Toxicogenomics is now developing. It
is defined as the study of the genes and
their products, which are important in
adaptive responses to toxic exposures
(Iannaccone 2001). One applicable and
efﬁcient method for developing this assess-
ment of fetal exposure to multiple chemi-
cals is the toxicogenomic analysis of
umbilical cords, using DNA microarray. 
Certain adverse health effects can be
prevented if symptoms are observed during
the postnatal period. Newborn diagnosis is
very important from the viewpoint of pre-
ventive medicine. Using toxicogenomic
analysis, if the new risk assessment of effects
of exposure to multiple chemicals is applied
to preventive medicine, it can possibly
secure the health of future generations.
In this commentary we introduce
a)asummary of our analysis of human fetal
exposure to multiple chemicals, b) our pre-
liminary toxicogenomic analysis of animals,
c) our toxicogenomic analysis of human
umbilical cords, d) technical problems and
socioethical issues to be resolved to make
this method more practical, and e) the
necessity of a worldwide effort to establish a
new risk assessment using toxicogenomic
analysis that focuses on the human fetus.
Analysis of Human Fetal
Exposure to Multiple
Chemicals
Our group has investigated human fetal
exposure to multiple chemicals in Japan by
analyzing umbilical cords and cord blood
(Mori 2001; Mori et al. 2001; Todaka and
Mori 2002). Human umbilical cords, part
of the fetal tissue, were collected from nor-
mal newborns. This study has been
approved by the Congress of Medical
Bioethics of Chiba University, Yamanashi
Medical College, and Kyoto University.
Informed consents of the mothers were
also obtained. 
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Our previous studies analyzing umbilical cords show that human fetuses in Japan are exposed
to multiple chemicals. Because of these findings, we believe it is necessary to establish a new
strategy for examining the possible delayed long-term effects caused by prenatal exposure to
multiple chemical combinations and evaluating the health risk to human fetuses. In this com-
mentary we describe our attempts to apply toxicogenomic analysis of umbilical cords, using
DNA microarray for future risk assessment. Because the umbilical cord is part of the fetal tis-
sue, it is possible to estimate the effects of chemicals on the fetus by analyzing alteration of the
gene expression. This type of toxicogenomic analysis could be a powerful and effective tool for
developing a new risk assessment strategy to help investigators understand and possibly prevent
long-term effects caused by fetal exposure to multiple chemicals. Worldwide cooperation is
needed to establish a new stragegy for risk assessment using toxicogenomic analysis that focuses
on the human fetus. Key words: delayed long-term effects, DNA microarray, human fetus,
multiple chemicals, risk assessment, toxicogenomics, umbilical cord. Environ Health Perspect
111:803–809 (2003). doi:10.1289/txg.5958 available via http://dx.doi.org/ [Online
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Toxicogenomics | CommentaryA summary of our previous studies
of human fetal exposure assessment is as
follows:
a) Multiple chemicals and toxicants
were detected in human umbilical cords or
cord serum. The detected chemicals and
toxicants were dioxins (polychlorinated
dibenzo-p-dioxins + polychlorinated
dibenzofurans + coplanar-PCBs), PCBs,
dichlorodiphenyltrichloroethane (DDT),
dichlorodiphenylchloroethane (DDE),
aldrin, chlordane, hexachlorobenzene
(HCB), hexachlorocyclohexane (BHC),
heavy metals (cadmium and lead), bisphe-
nol A, and phytoestrogens (Mori 2001;
Mori et al. 2001; Todaka and Mori 2002).
All these chemicals and toxicants were
detected in more than 50% of the umbili-
cal cords investigated in our studies. Some
umbilical cord data showed large amounts
of several chemicals (Todaka and Mori
2002). As a result of these findings, it is
now clear that fetuses in Japan are exposed
to multiple chemicals. 
b) Concentrations of persistent chemi-
cals such as dioxins, PCBs, and DDT and
its metabolites in human umbilical cords of
first-, second-, and thirdborn babies were
examined and compared. Concentrations
of dioxins, PCBs, and DDT, and its
metabolites seem to be higher in ﬁrst born
babies than in second- or thirdborn babies
(Mori et al. 2001).
There are correlations between the con-
centrations of PCBs and other persistent
chemicals such as p,p´-DDE, HCB, and
BHC in human umbilical cords (Figure 1).
Individuals who accumulated PCBs at
higher levels also accumulated other persis-
tent chemicals at higher levels. As shown in
Figure 1, three umbilical cords that had
accumulated levels of PCBs greater than
200 pg/g-wet weight also showed high
levels of p,p´-DDE, HCB, and BHC.
There are two possible reasons for this.
One is that these people might have been
highly exposed because of their eating
habits or because they are living (or used to
live) in an area polluted by these chemicals.
Another possible reason is that these people
may have lower abilities to exclude the
chemicals because of speciﬁc genetic back-
grounds. This analysis suggests that there
are fetuses highly exposed to multiple
persistent chemicals in Japan.
From the above, it is clear that at least
20 chemicals and toxicants have been
transplacentally transferred from mothers
to their fetuses. Moreover, some fetuses are
more highly exposed to multiple chemicals
(Mori 2001; Mori et al. 2001; Todaka and
Mori 2002). 
There is no evidence these situations
will cause any adverse health effects in
children in the future. However, reports
from animal experiments and wildlife ani-
mal disorders give us genuine concern
about possible delayed long-term adverse
health effects on humans (Colborn et al.
1996). Diethylstilbestrol (DES) is a syn-
thetic estrogen commonly used for preg-
nant women until the1970s to prevent
miscarriage. Delayed long-term effects, typ-
ically reported as DES syndrome, are phe-
nomena caused by fetal exposure to DES
that do not emerge until a child reaches
puberty, or sometime later in life (Colborn
et al. 1996; Herbst et al. 1971, 1974;
McLachlan et al. 2001). Because the human
fetus is toxicologically much more sensitive
to chemicals than adults (Calabrese 1986;
Jacobson and Jacobson 1996; Moore and
Persaud 1998; Needleman 1979; Perera
1996; Perera et al. 2002; WHO 1986;
Whyatt and Perera 1995), it is important
that the scientific community establish a
new method of risk assessment that con-
siders human fetal exposure to multiple
chemicals.
Our Preliminary Toxicogenomic
Analysis of Animals
In the past 5 years, toxicogenomics has
become a remarkable scientific field that
combines studies of genetics, genomewide
mRNA expression, cellwide and tissuewide
protein expression, bioinformatics, and
toxicology to understand the roles of
gene–environment interactions in diseases
(Bartosiewicz et al. 2000; Iannaccone
2001; Lobenhofer et al. 2001; Medlin
1999; Nuwaysir et al. 1999; Rockett and
Dix 1999; Tennant 2002). Toxicogenomic
analysis using DNA microarray is a power-
ful and high-throughput method for moni-
toring the expression of thousands of genes
simultaneously (Adachi et al. 2002;
Duggan et al. 1999; Hossain et al. 2000;
Komiyama et al. 2002; Rockett and Dix
1999). If gene expression profiles can be
used as a predictive parameter, toxicoge-
nomic analysis using microarrays would be
an ideal tool for developing risk assessment
of chemicals (Iannaccone 2001).
Our group conducted animal experi-
ments to investigate the long-term alter-
ation of gene expression affected by
neonatal exposure to estrogenic com-
pounds in mouse testis (Adachi et al. 2002;
Komiyama et al. 2002; Shibayama et al.
2001). Male and female reproductive
organs including testis and uterus are vul-
nerable to estrogenic compounds. The
estrogenic compounds used in the experi-
ments were DES and genistein (a phyto-
estrogen produced by plants).
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Figure 1. Correlation analysis between the people who accumulated high amounts of PCBs and the people who accumulated high amounts of p,p´-DDE (A), HCB
(B), and BHC (C). The number of samples in each analysis is 19, 11, and 19, respectively. The amount of each chemical is expressed as picograms per gram tissue
wet weight. The group including fetuses highly exposed to multiple chemicals is shown as ﬁlled circles. In these data, three samples are included in the multiple
highly exposed group.The goal of our investigation was to
determine if toxicogenomic analysis at the
molecular level could detect a delayed long-
term effect that cannot be detected by con-
ventional toxicological assessment. Table 1
is a summary of the data from our experi-
ments and others (Adachi et al. 2002;
Komiyama et al. 2002; McLachlan et al.
2001; Newbold 2001; Newbold et al.
1984, 2002; Shibayama et al. 2001). The
table shows the effects of neonatal exposure
to DES or genistein in experimental ani-
mals at three different end points (gene
expression level, reproductive disorder
level, and cancer level). The gene expres-
sion level was examined by toxicogenomic
analysis during weeks 4–12 after neonatal
exposure. The reproductive disorder level
was examined by conventional toxicologic
assessment at week 12 after neonatal expo-
sure. The cancer level shows the delayed
long-term effect. The delayed long-term
effect was detected as the form of adeno-
carcinoma in the uterus at month 18 after
neonatal exposure (Newbold 2001;
Newbold et al. 2002). 
Details are as follows: a) Neonatal
exposure to DES in animal experiments
can cause marked atrophy of the testes, tes-
ticular carcinoma, uterine adenocarcino-
mas, and carcinoma of cervicovaginal
region (Arai et al. 1983; McLachlan et al.
2001; Newbold 2001; Newbold et al.
1984; Visser et al. 1998). In our experi-
ments, DES caused several adverse effects
as reported before by conventional experi-
mental methods. Furthermore, using mole-
cular level analysis, we were able to detect
long-term alteration of gene expression
(Shibayama et al. 2001). 
b) Neonatal exposure to genistein in
animal experiments has been reported to
cause uterine adenocarcinomas (Newbold
et al. 2002), but other adverse effects
have not been reported. Using the con-
ventional method in our experiment, we
did not detect any other effects. However,
long-term altered gene expressions at
mRNA and protein levels were found
(Shibayama et al. 2001). The evalution
presented in Table 1 shows that delayed
long-term effects not detectable with the
conventional method can be detected at
the molecular level with toxicogenomic
analysis. 
c) Next, using DNA microarray, our
group conducted experiments to examine
global gene expression that was altered in
the long term. The effect of neonatal expo-
sure to DES (50 µg/mouse/day) on mouse
testicular gene expression was examined
using in-house cDNA microarray (Adachi
et al. 2002; Komiyama et al. 2002). The in-
house cDNA microarray contained 2,304
cDNA probes prepared from mouse fetuses
(day 14.5). As a result, 11 genes were
upregulated (more than 1.5-fold) at expres-
sion levels in DES-treated mice 4 weeks of
age. Real-time reverse transcription–poly-
merase chain reaction (RT–PCR) analysis
also revealed that expression levels of 8 of
11 genes were still higher in DES-treated
testes at 8 and 12 weeks of age (Adachi et
al. 2002). Moreover, transitions of gene
expression proﬁles in testes of DES-treated
mice were also investigated during 4–12
weeks of age using the in-house cDNA
microarray (Table 2). Many of the genes
affected by DES were upregulated or down-
regulated at restricted periods (Table 2, pat-
terns B–F, J–L), but some genes were
continuously upregulated (Table 2, pattern
A) or shifted from a downregulated state to
an upregulated state (Table 2, patterns G–I)
(Komiyama et al. 2002).
As above, with toxicogenomic analysis
using cDNA microarray, we proved that
neonatal exposure to chemicals induces
long-term effects on testicular gene expres-
sion in adult mice. Moreover, global analysis
using DNA microarray can detect some
genes that are upregulated or downregulated
continuously by chemical exposure. Such
genes can be a biomarker to predict adverse
effects caused by chemicals. Bartosiewicz
et al. (2000) also recently reported that
microarray is a powerful tool to evaluate
the effects of multiple chemical exposure.
Several studies by our lab and others, using
animals, have shown that application of
toxicogenomic analysis to human risk
assessment of multiple chemical exposure is
possible.
Our Toxicogenomic Analysis
of Human Umbilical Cords
Microarray technology has been used in
many human studies such as cancer
research. Some of the main objectives of
using microarray technology in human
cancer research are to improve differential
diagnosis of malignant neoplasia and to
increase the effectiveness of therapeutics
(Lobenhofer et al. 2001). Microarray tech-
nology has been applied to a field of toxi-
cology using animal experiments and will
be applied to the ﬁeld of risk assessment of
human exposure to several environmental
toxicants. A recent study using cDNA
microarray by Hossain et al. (2000)
reported the identiﬁcation of lead-sensitive
genes in immortalized human fetal astro-
cytes. The study showed the potential of
DNA microarray in the discovery of novel
toxicant-induced gene expression alter-
ations and in the understanding of the
mechanisms underlying lead neurotoxicity. 
As mentioned above, we are newly
applying toxicogenomic analysis using
Toxicogenomics | Toxicogenomic analysis using human umbilical cords
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Table 1. Evaluation of effects of neonatal exposure to DES or genistein at three different end points in mice.
End points
Gene expression level (4–12 weeks)a Reproductive disorder level (12 weeks)a Cancer level (18 months)a
Evaluation methods Toxicogenomic analysis Conventional toxicologic assessment Delayed long-term effect 
DES Alteration of gene expression Adverse effects Adenocarcinomab
Genistein Alteration of gene expression No adverse effects Adenocarcinomab
aTerm after neonatal exposure to chemicals. bData from Newbold (2001) and Newbold et al. (2002).
Table 2. Transition of gene expression change in testes of neonatally DES-treated mice during 4–12
weeks of age using microarray analysis.
Transition pattern 4 weeks 8 weeks 12 weeks Number of genes
AU p U p U p 1
BU p U p – 3
CU p – – 2 1
D– U p Up 6
E– U p – 2 7
F– – U p 7
G Down Up Up 1
H Down Up – 1
I Down – Up 2
J Down – – 12
K– Down – 8
L– – Down 3
M Down Down Down 0
Abbreviations: Down, downregulated more than 2-fold; Up, upregulated more than 2-fold; –, same as control. DNA microarray to develop a new risk
assessment method to evaluate the effects
of chemicals. Figure 2 shows our challeng-
ing framework to establish toxicogenomic
analysis using human umbilical cords for
this purpose. Because the umbilical cord is
part of the fetal tissue, it is possible to esti-
mate the effects of chemicals on the fetus
by analyzing alteration of the gene expres-
sion. In addition, it is easy to collect the
umbilical cords technically and socially.
Therefore, the use of umbilical cords for
risk assessment of chemical effects on the
fetus seems to be an ideal method. 
We are developing this new risk
assesment method using four steps (Figure 2).
Step 1 analysis is the global gene expression
analysis of the umbilical cords by DNA
microarray. Step 2 analysis is a combined
analysis of the data from Step 1 and expo-
sure assessment data in each umbilical cord.
In this analysis a relationship between a
global gene expression proﬁle and chemical
exposure levels will be clarified. Step 3
analysis using an in vitro experiment is
DNA microarray analysis of the alteration
of gene expression in human umbilical
cord–derived cells (HUCCs) after exposure
to chemicals. For this purpose, human
umbilical vein endothelial cells (HUVEC)
is one of the candidates, as we found that
HUVEC genes changed their expression
after chemical exposure. Although HUVEC
can be applied in this step, other cells from
umbilical cords also may be applicable. Step
4 analysis is an integrated analysis of a com-
parison between Step 2 and Step 3. In this
integrated analysis, biologic reactions at the
molecular level caused by exposure to
chemicals in fetuses can be detected. To
extend the toxicogenomic analysis method
to develop a new risk assessment strategy,
comprehensive studies are required to clar-
ify the correlation between data from
toxicogenomic analysis, data from animal
experiments observing the adverse effects of
chemical exposure, and data from human
prospective studies. By establishing the
toxicogenomic analysis with the in silico
integrated analysis of human umbilical
cords, the new risk assessment for multiple
chemical exposures will be practical.
However, in establishing the procedure
for toxicogenomic analysis, some doubt the
possibility of detecting alterations of gene
expressions because the umbilical cord is
not the target organ affected by the chemi-
cals. Others doubt if toxicogenomic analy-
sis using microarray is possible with
umbilical cords. To answer these questions
and to prove the importance of toxico-
genomic analysis using umbilical cords, we
conducted the following two preliminary
experiments.
First, the total RNA was puriﬁed from
umbilical cords (n = 5), and RT–PCR
analysis was conducted. As a result,
mRNAs of cytochrome P450 (CYP) 1A1,
CYP1A2, CYP1B1, and sex hormone
receptors were detected in human umbili-
cal cords. We also found the difference of
expression levels of mRNA of CYP1A1 in
each umbilical cord (unpublished data).
These results show that umbilical cords can
be targets for toxicogenomic analysis.
Second, to conduct a toxicogenomic
analysis of umbilical cords, alteration of
the gene expression proﬁle was analyzed in
five umbilical cords using the human I
cDNA microarray (human 15154 genes;
Agilent Biotechnology, Japan, Tokyo,
Japan). As a reference, we used the mRNA
puriﬁed from HUVEC (Cell Applications,
Inc., San Diego, CA, USA). Global analy-
sis of gene expression profiles in five
umbilical cords showed that more than
7,000 of 15,154 genes were expressed in
umbilical cords, and expression levels of
265 of more than 7,000 genes were higher
or lower than the expression levels of those
Toxicogenomics | Mori et al.
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Figure 2. Challenging framework to establish toxicogenomic analysis of multiple chemical exposure using
umbilical cords for new risk assessment to decrease the risks to future generations. in the HUVEC. Approximately 6,800
genes did not show any alteration in
expression levels between the umbilical
cord and HUVEC. Among at least four
umbilical cords, the number of genes
commonly altered was only 27. Moreover,
we found variations in gene expression
patterns (Figure 3). Some genes, such
as X53331 (matrix Gla protein) and
AA314429 (expression sequence tag
[EST], similar to ribosomal protein S12),
were upregulated in some umbilical cords
and downregulated in others. Conversely,
some genes such as M60527 (deoxycyti-
dine kinase) were downregulated among
all five umbilical cords. (Gene accession
numbers are from the GenBank database
[http://www.ncbi.nlm.nih.gov].) These
results indicate that DNA microarray
analysis of each umbilical cord can detect
individual differences of gene expression.
In summary, the analysis using DNA
microarray could reveal global gene expres-
sion alterations and detect individual differ-
ences in gene expression in each umbilical
cord. The next step would be to increase
the number of cord samples and analyze in
silico both the data from toxicogenomic
analysis and exposure assessment. 
As it is already used in the ﬁeld of cancer
research, if the approach shown in Figure 2
becomes practical, the toxicogenomic
analysis can be used for the early diagnosis
and possible prevention of adverse effects
caused by multiple chemicals in humans.
Technical Problems and
Socioethical Issues to Be
Resolved
Although the toxicogenomic analysis using
human umbilical cords can be an ideal
method to predict possible future effects in
humans, certain technical and socioethical
points must be cleared to make it more
practical.
First, a technical problem is the choice
of reference. For this study, we chose
HUVEC as a reference because we expected
the gene expression pattern after exposure
would be useful in HUCCs. However, as it
is from human tissue, the genetic back-
ground differs from one HUVEC sample
to another.
Second, investigators must be certain if
an alteration in a microarray expression
profile is a sign of a future adverse effect.
At this stage an adverse effect is only sus-
pected; however, if genes alter with chemi-
cal exposure, it could be a sign of some
delayed long-term effect. It is therefore
very important to accumulate information
about the gene expression profile for the
time when the meaning of the gene expres-
sion changes becomes clear. In addition, as
mentioned above, comprehensive studies
are required to clarify the correlation
between the data from toxicogenomic
analysis and data from chemical exposure
experiments in animals. Moreover, if the
toxicogenomic analysis data from each
umbilical cord can be compared with data
from prospective survey studies that follow
up on the growth of the cord-related
babies, the correlation between the two
types of data from the toxicogenomic
analysis and the human follow-up surveys
could clarify the effectiveness of the newly
developed risk assessment.
Third, as the toxicogenomic analysis
method develops, socioethical issues sur-
face. Naturally, researchers must receive
informed consent from parents. In addi-
tion, information on gene expression with
each umbilical cord should be managed
properly and restricted to authorized use.
Fourth, because of the sensitive nature
of the implications of the results,
researchers must prepare for emotional
care of the involved subjects and parents.
With the rapid growth of toxicogenomics
and environmental genome projects
(Guengerich 1998; Shalat et al. 1998;
Sharpe and Barrett 2000), people can now
obtain an individual analysis of multiple
chemical exposure addressing exposure lev-
els, toxicogenomic analysis data, and
genetic background. Susceptibilities of
individuals to chemicals will differ, mainly
because of the unique genetic background
of each individual (Guengerich 1998;
Shalat et al. 1998; Sharpe and Barrett
2000; Spearow et al. 1999). When a
child’s exposure level, toxicogenomic
analysis data (gene expression level at pre-
sent), and genetic background become
clear, parents should be made clearly aware
of this information, e.g., their children’s
exposure levels to which chemicals, how
sensitive their children are to these chemi-
cals, and how their children might be
affected by these chemicals. How this
information will be sensitively presented
and how parents might emotionally
respond need to be carefully planned.
Researchers must develop a system that
both accurately informs and sensitively
cares for the involved parents. People who
are informed of their own or their chil-
dren’s toxicogenomic analysis data should
also be told of whatever methods are
known and available to reduce the risk of
possible adverse effects. 
Last, perhaps of greatest concern are
the attempts to decrease the presence of
these unwanted chemicals in our environ-
ment and to develop methods to decrease
the amount of accumulated chemicals
already present in our bodies. We have
Toxicogenomics | Toxicogenomic analysis using human umbilical cords
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Figure 3. Individual differences of gene expression of some genes in each umbilical cord. 
aGenBank
accession numbers are from the GenBank database (http://ncbi.nlm.nih.gov): X53331, matrix Gla protein;
AA314429, EST, similar to ribosomal protein S12; M60527, deoxycytidine kinase.established a framework to begin reducing
levels of exposure through communication
to the public of risk factors (Todaka and
Mori 2002). Other groups are also trying
to prevent chemical exposure to fetuses
and infants in many ways. For example,
Perera et al. (2002) have introduced a
program of preventive methods against
environmental toxicants in New York
City. The U.S. National Institute of
Environmental Health Sciences and U.S.
Environmental Protection Agency have
created 12 children’s environmental health
research centers in the United States and
are trying to reduce the risk of exposure to
chemicals and prevent damage to children
(Wakeﬁeld 2002).
Conclusion
Increasing evidence clearly proves that
human fetuses are contaminated by expo-
sure to multiple chemicals. The currently
accepted risk assessment focusing on the
adverse effects of only single chemicals on
only mature adults does not address this
fact. Fetal exposure to multiple chemicals
and the possible future adverse effects of
these chemical combinations should be
considered. Although the correlation
between exposure to chemicals and adverse
health effects such as congenital anomalies,
disorders of the reproductive, immune, and
nervous systems, etc., are not entirely clear.
It is the responsibility of the people living
in our modern society to decrease possible
risks to future generations. 
In this commentary we highlight the
possible utility of developing a new risk
assessment strategy using toxicogenomic
analysis of umbilical cords by DNA
microarray (Figure 2). As mentioned
above, many steps are required to establish
an accurate toxicogenomic analysis
method using umbilical cords, and techni-
cal problems and socioethical issues still
must be surmounted. However, when
these problems are resolved, we are hope-
ful the new risk assessment strategy with
toxicogenomic analysis can be applied to
prevent the long-term effects of multiple
chemical exposure. Furthermore, if the
new risk assessment involves cooperation
from current environmental genome pro-
jects, it could possibly lead to the develop-
ment of new tailor-made preventive
medicines.
The problems of multiple chemical
exposure are not conﬁned to Japan. People
throughout the world are exposed to similar
or even worse conditions of environmental
contamination. Worldwide cooperation is
necessary to establish a new risk assessment
using toxicogenomic analysis focusing on
the human fetus.
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